Psychiatr. pro Praxi, 2008; 9(1): 40-43

Nové trendy v léčbě schizofrenie

prof. MUDr. Eva Češková CSc
Psychiatrická klinika LF MU a FN Brno

Schizofrenie je dnes považována za celoživotní onemocnění s přetrvávajícími příznaky a občasnými relapsy (exacerbace psychotické, pozitivní symptomatologie). Jedná se o progresivní onemocnění mozku s redukcí šedé hmoty mozkové. Dle současných představ by léčba schizofrenie měla být 1. dlouhodobá a kontinuální, 2. komplexní, 3. individualizovaná a 4. měřitelná.

Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Češková E. Nové trendy v léčbě schizofrenie. Psychiatr. praxi. 2008;9(1):40-43.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Andreasen NC, Carpenter WT Jr, Kane JM et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-449. Go to original source... Go to PubMed...
    2. Češková E. Schizofrenie a její léčba. 2. vydání. Praha: Jessenius Maxdorf, 2007; 104 s.
    3. Češková E, Tůma I, Přikryl R, Pěč O. Schizofrenie V: Raboch J, Anders M, Praško J, Kellerová P. Psychiatrie. Doporučené postupy léčby psychiatrické péče II. Praha: Infopharm 2006; 54-63.
    4. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 2004; 27: 596-600.
    5. Davis JM. Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry 1975; 132: 1237-1245. Go to original source... Go to PubMed...
    6. Falkai P, Wobrock T, Liberman J et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part I: acute treatment of schizophrenia. World J Biol Psychiatry 2005; 6: 132-191. Go to original source... Go to PubMed...
    7. Gottdiener WH, Haslam N. The benefits of individual psychotherapy for people diagnosed with schizophrenia: a meta-analytic review. Ethical Human Sciences and Services 2002; 4:163-187.
    8. Kay S, Fiszbein A, Opler LA. The positive and negative syndrome scale. Schizophr Bull 1987; 13: 261-276. Go to original source... Go to PubMed...
    9. Masopust J. Praktické tipy pro sledování bezpečnosti při dlouhodobé léčbě antipsychotiky. Psychiatr. pro Praxi 2007; 4: 180-184.
    10. McIntyre JS, Charles SC et al. APA Practice guidelines for the treatment of psychiatric disorders. Compendium, 2004; 1091.
    11. Meltzer HY. Suicide and schizophrenia: clozapine and the InterSePT study. J Clin Psychiatry, 60, 1999; 60 (Suppl 12): 47-50.
    12. Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database Syst. Rev 2002; CD002831. Go to original source...
    13. Robinson D, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241-247. Go to original source... Go to PubMed...
    14. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995; 21: 419-429. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.